Lv1
40 积分 2021-11-12 加入
Glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors as combination therapy for type 2 diabetes: A systematic review and meta-analysis
10个月前
已完结
Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial
1年前
已关闭
Decreased circulating BMP-9 levels in patients with Type 2 diabetes is a signature of insulin resistance
1年前
已完结
Prevalence of cardiovascular disease risk factors in Chinese patients with type 2 diabetes mellitus, 2013-2018
2年前
已完结
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
2年前
已完结
The rise and rise of drug delivery
3年前
已完结
Half-Life Extension of Biopharmaceuticals using Chemical Methods: Alternatives to PEGylation
3年前
已完结
皖公网安备34019202002308
